Wolverine Trading’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Hold |
0
| – | – | – | 1325 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 1516 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 1322 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 1246 |
|
2024
Q1 | – | Hold |
0
| – | – | – | 1195 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 1264 |
|
2023
Q3 | – | Sell |
-20,198
| Closed | -$18.7K | – | 1166 |
|
2023
Q2 | $18.7K | Buy |
+20,198
| New | +$18.7K | ﹤0.01% | 1041 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 1058 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 1002 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 1223 |
|
2022
Q1 | – | Sell |
-12,536
| Closed | -$29K | – | 1521 |
|
2021
Q4 | $29K | Buy |
+12,536
| New | +$29K | ﹤0.01% | 1591 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 1915 |
|
2021
Q2 | – | Sell |
-27,071
| Closed | -$84K | – | 1787 |
|
2021
Q1 | $84K | Sell |
27,071
-316
| -1% | -$981 | ﹤0.01% | 1648 |
|
2020
Q4 | $82K | Buy |
27,387
+7,995
| +41% | +$23.9K | ﹤0.01% | 1356 |
|
2020
Q3 | $46K | Buy |
19,392
+7,358
| +61% | +$17.5K | ﹤0.01% | 1161 |
|
2020
Q2 | $153K | Buy |
12,034
+1,587
| +15% | +$20.2K | ﹤0.01% | 1046 |
|
2020
Q1 | $83K | Sell |
10,447
-9,515
| -48% | -$75.6K | ﹤0.01% | 1114 |
|
2019
Q4 | $131K | Buy |
19,962
+4,430
| +29% | +$29.1K | ﹤0.01% | 1285 |
|
2019
Q3 | $64K | Sell |
15,532
-517
| -3% | -$2.13K | ﹤0.01% | 1187 |
|
2019
Q2 | $78K | Buy |
+16,049
| New | +$78K | ﹤0.01% | 1096 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 1191 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 1296 |
|